November 27, 2017 Cerevance Appoints David H. Margolin, M.D., Ph.D., as Senior Vice President of Clinical and Translational Medicine
October 24, 2017 Trailblazer in Molecular Genetics and Neuroscience, Jeremy Nathans, M.D., Ph.D., to Advise Cerevance
October 17, 2017 Cerevance Licenses Human Brain Tissue Profiling Technology from The Rockefeller University
October 12, 2017 Harvard’s Rudolph Tanzi, Ph.D., a Leader in Alzheimer’s Disease Genetics, Joins Cerevance’s Advisory Board
December 2, 2016 Cerevance Launched With New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases
